MIK665
CAS No. 1799631-75-6
MIK665 ( S-64315;MIK-665;S64315 )
Catalog No. M12722 CAS No. 1799631-75-6
MIK665 (S-64315, MIK-665) is a novel potent, selective Mcl-1 inhibitor with potential pro-apoptotic and antineoplastic activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 260 | Get Quote |
|
10MG | 410 | Get Quote |
|
25MG | 678 | Get Quote |
|
50MG | 954 | Get Quote |
|
100MG | 1287 | Get Quote |
|
500MG | 2574 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMIK665
-
NoteResearch use only, not for human use.
-
Brief DescriptionMIK665 (S-64315, MIK-665) is a novel potent, selective Mcl-1 inhibitor with potential pro-apoptotic and antineoplastic activities.
-
DescriptionMIK665 (S-64315, MIK-665) is a novel potent, selective Mcl-1 inhibitor with potential pro-apoptotic and antineoplastic activities; binds to and inhibits the activity of Mcl-1, which promotes apoptosis of cells overexpressing Mcl-1. Mcl-1, an anti-apoptotic protein belonging to the Bcl-2 family of proteins, is upregulated in cancer cells and promotes tumor cell survival.Blood Cancer Phase 1 Clinical
-
SynonymsS-64315;MIK-665;S64315
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1799631-75-6
-
Formula Weight875.41
-
Molecular FormulaC47H44ClFN6O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 125 mg/mL 142.79 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(O)[C@@H](CC1=C(OCC2=NC(C3=C(OC)C=CC=C3)=NC=C2)C=CC=C1)OC4=C5C(SC(C6=CC=C(F)C=C6)=C5C7=C(C)C(Cl)=C(OCCN8CCN(C)CC8)C=C7)=NC=N4
-
Chemical Name(R)-2-((5-(3-chloro-2-methyl-4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl)oxy)-3-(2-((2-(2-methoxyphenyl)pyrimidin-4-yl)methoxy)phenyl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cassier PA, et al. Br J Cancer. 2017 Oct 10;117(8):1089-1098.
molnova catalog
related products
-
FX1
A potent, specific BCL6 BTB domain inhibitor with Kd of 7 uM, binds with a greater affinity than the natural BCL6 ligand SMRT (Kd=30 uM).
-
AZD 4320
AZD4320 is a BH3 mimetic and dual Bcl-2/Bcl-XL inhibitor with IC50 of <1 nM.
-
BI-3812
A highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.